BAV

Bavarian Nordic

Action
Action
ISIN: DK0061268711
DK0061268711

Price

Prix

GRAPH PAR

Informations

Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark.

Industries
Pharmaceuticals: Major
Secteur
Soins de santé

Identifiant

ISIN
DK0061268711

Les Knockouts

Participez à la discussion